Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2022-10-14 2023-04-06 171836
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-10-21 2023-03-16 172351
APO-MIRTAZAPINE 30MG TABLET Resolved 2022-12-09 2023-01-06 177603
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-09 2023-03-16 177606
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-03-16 178751
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178784
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178787
APO-CINACALCET 30MG TABLET Resolved 2023-01-13 2023-01-26 181113
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-01-20 2023-01-26 181970
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-09 2023-03-16 184089
APO-MIRTAZAPINE 30MG TABLET Resolved 2023-04-14 2023-08-04 189644
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-06 2023-05-26 191877
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-19 2023-06-09 192796
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-07 2023-09-15 197879
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-PAROXETINE 30MG TABLET Resolved 2023-09-22 2023-10-06 205018
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-06 2024-01-05 206560
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-27 2024-01-05 208417

Showing 1181 to 1200 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-NITRAZEPAM 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-TERAZOSIN 5MG TABLET Discontinued 2017-03-30 2018-02-05 4749
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2018-10-12 60450
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090

Showing 21 to 40 of 356